Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Summer;28(4):31-41.

Medicaid's expenditures for newer pharmacotherapies for adults with disabilities

Theresa I Shireman  1 , Jean P Hall, Sally K Rigler, Janice M Moore
Affiliations

Medicaid's expenditures for newer pharmacotherapies for adults with disabilities

Theresa I Shireman et al. Health Care Financ Rev. 2007 Summer.

Abstract

Medicaid's drug expenditures have grown at double-digit inflation rates since 2000. These prescription drug costs are important contributors to increasing health care costs for disabled persons. In spite of this knowledge, little has been reported about specific patterns of medication use among disabled enrollees. We analyzed Kansas Medicaid data to describe trends in medication use patterns across 3 years among disabled beneficiaries. The marked shifts toward newer medications and disproportionate contributions of newer, more expensive medications to overall prescription costs for antipsychotics, antidepressants, anticonvulsants, antiulcer medications, anti-inflammatory agents, and opioids have implications for both policy and practice.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Market Shares as Percent of Prescriptions and Expenditures for Newer Agents in Major Therapeutic Classes Used in the Kansas Medicaid Disabled Program: 2001-2002
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Baugh D, Pine P, Blackwell S, et al. Medicaid Prescription Drug Spending in the 1990s: A Decade of Change. Health Care Finance Review. 2004 Spring;25(3):5–23. - PMC - PubMed
    1. Centers for Disease Control and Prevention. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Internet address: http://www.cdc.gov/nchs/about/otheract/icd9/abticd9.htm (Accessed 2007.)
    1. Crowley JS, Ashner D, Elam L. State Medicaid Outpatient Prescription Drug Policies: Findings from a National Survey, 2005 Update. The Henry J. Kaiser Family Foundation; Washington, DC.: Oct, 2005. Internet address: http://www.kff.org/medicaid/7381.cfm (Accessed 2007.)
    1. Dai C, Stafford R, Alexander G. National Trends in Cyclooxygenase-2 Inhibitor Use Since Market Release: Nonselective Diffusion of a Selectively Cost-Effective Innovation. Archives of Internal Medicine. 2005 Jan;165:171–177. - PubMed
    1. Federal Register: Medicare Program; Medicare Prescription Drug Benefit; Final Rule. Jan 28, 2005. 42 CFR Parts 400, 403, 411, 417, and 423. - PubMed

Publication types